ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Infections in Simultaneous Pancreas/Kidney Transplant (SPKT) Recipients

J. W. O'Neill1, M. J. Copeland2, S. D. Schrank2, M. Cooper3, P. Abrams3, B. Javaid3, J. G. Timpone2

1Georgetown University School of Medicine, Washington, DC, 2Division of Infectious Diseases and Travel Medicine, Medstar Georgetown University Hospital, Washington, DC, 3Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC

Meeting: 2020 American Transplant Congress

Abstract number: A-255

Keywords: Infection, Kidney/pancreas transplantation, Outcome

Session Information

Session Name: Poster Session A: Pancreas and Islet: All Topics

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Simultaneous pancreas/kidney transplant (SPKT) is indicated for diabetic patients (pts) with chronic kidney disease and represents the largest proportion of pancreas transplants performed. Infection is a common complication post SPKT; however, etiologies and risk factors need further characterization.

*Methods: We performed a retrospective chart review of all pts who underwent an SPKT from 2015 – 2018 at our center. Pts demographics/outcomes, infection episodes, rejection episodes, and post-operative complications were collected for up to 180 days post SPKT. Fisher’s Exact test, Student’s T-Test and descriptive statistics were used.

*Results: 71 pts underwent SPKT during the observation period with the following characteristics: 58% male, mean age 43.5 years, mean length of stay (LOS) 8.5 days post SPKT, rate of return to OR in 30 days 16.9% (12/71), rejection rate of 25.4% (18/71), and mean readmission rate within 90 days 57.7% (41/71). 84.5% (60/71) of pts developed a total of 143 infection episodes within 180 days post SPKT and 65% (39/60) of those pts developed >1 infection episode. The mean time to onset of first infection was 55.3 days, with a median of 27.5 days for bacterial, 51 days for fungal, and 90 days for viral infection. The most common laboratory confirmed infections were as follows: 46.7% (28/60) bacterial, 11.7% (8/60) fungal, and 65.0% (39/60) viral. The most common sites of laboratory confirmed bacterial infections were urine (47.3%), blood stream (23.6%), and surgical site/organ space (14.6%). 12.7% (9/71) developed MDR infections (5.6% {4/71} with C. difficile). The most common fungus isolated was candida species; there was one episode of cryptococcal meningitis and one episode of invasive pulmonary aspergillosis identified. CMV infection occurred in 35.2% (25/71) of pts with a mean time from SPKT to CMV infection of 122 days. BKV viruria/viremia occurred in 36.6% (26/71) of pts with a mean time of 41 days post SPKT; 69.2% (18/26) of these pts had a reduction in immunosuppression. For patients with infections vs those without infection, there were no statistical differences with the following comparisons: kidney rejection (8% vs. 0%; p=1), dialysis post-transplant (12% vs 0%; p=0.59), pancreas rejection (18.3% vs 27.3% p=0.41), readmission within 90 days from initial transplant (62% vs 36%; p=0.184), return to OR within 30 days (18% vs 9%; p=0.68), or LOS after SPKT (8.5 vs 8.3 days; p=0.81). During 6 months of followup, overall patient survival was 97.2%; infection contributed to the cause of death in 2 pts.

*Conclusions: High rates of infection occur in SPKT recipients during the 6 month post transplant period, but despite this patient outcomes were favorable.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

O'Neill JW, Copeland MJ, Schrank SD, Cooper M, Abrams P, Javaid B, Timpone JG. Infections in Simultaneous Pancreas/Kidney Transplant (SPKT) Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/infections-in-simultaneous-pancreas-kidney-transplant-spkt-recipients/. Accessed May 16, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences